These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36551062)

  • 1. A Proof-of-Concept Electrochemical Skin Sensor for Simultaneous Measurement of Glial Fibrillary Acidic Protein (GFAP) and Interleukin-6 (IL-6) for Management of Traumatic Brain Injuries.
    Shahub S; Lin KC; Muthukumar S; Prasad S
    Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease.
    Jagannath B; Lin KC; Pali M; Sankhala D; Muthukumar S; Prasad S
    Inflamm Bowel Dis; 2020 Sep; 26(10):1533-1542. PubMed ID: 32720974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device.
    Jagannath B; Lin KC; Pali M; Sankhala D; Muthukumar S; Prasad S
    Bioeng Transl Med; 2021 Sep; 6(3):e10220. PubMed ID: 34589597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid.
    Zwirner J; Bohnert S; Franke H; Garland J; Hammer N; Möbius D; Tse R; Ondruschka B
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury.
    Button EB; Cheng WH; Barron C; Cheung H; Bashir A; Cooper J; Gill J; Stukas S; Baron DC; Robert J; Rowe EM; Cripton PA; Wellington CL
    Alzheimers Res Ther; 2021 Mar; 13(1):58. PubMed ID: 33678186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Variable Height Microfluidic Device for Multiplexed Immunoassay Analysis of Traumatic Brain Injury Biomarkers.
    Krausz AD; Korley FK; Burns MA
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury.
    Schiff L; Hadker N; Weiser S; Rausch C
    Mol Diagn Ther; 2012 Apr; 16(2):79-92. PubMed ID: 22497529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Microfluidic-Transistor Sensing System for Multiplexed Detection of Traumatic Brain Injury Biomarkers.
    Yu S; Pan Y; Tang L; Wu S; Liang C; Zhang GJ; Li YT
    ACS Sens; 2024 Jun; 9(6):3017-3026. PubMed ID: 38889364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLASP (Continuous lifestyle awareness through sweat platform): A novel sensor for simultaneous detection of alcohol and glucose from passive perspired sweat.
    Bhide A; Muthukumar S; Prasad S
    Biosens Bioelectron; 2018 Oct; 117():537-545. PubMed ID: 29982125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoporous Carbon Immunosensor for Highly Accurate and Sensitive Clinical Detection of Glial Fibrillary Acidic Protein in Traumatic Brain Injury, Stroke, and Spinal Cord Injury.
    Khetani S; Salahandish R; Tabor JB; Chilvers M; Dukelow S; Ho C; Campbell C; Sen A; Debert CT; Sanati-Nezhad A
    ACS Biomater Sci Eng; 2023 Jun; 9(6):3556-3569. PubMed ID: 37067234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-Biomarker Detection Following Traumatic Brain Injury.
    Cardinell BA; Addington CP; Stabenfeldt SE; La Belle JT
    Crit Rev Biomed Eng; 2019; 47(3):193-206. PubMed ID: 31679255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmon-enhanced near-infrared fluorescence detection of traumatic brain injury biomarker glial fibrillary acidic protein in blood plasma.
    Zheng P; Kasani S; Tan W; Boryczka J; Gao X; Yang F; Wu N
    Anal Chim Acta; 2022 Apr; 1203():339721. PubMed ID: 35361421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
    Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.
    Posti JP; Takala RSK; Lagerstedt L; Dickens AM; Hossain I; Mohammadian M; Ala-Seppälä H; Frantzén J; van Gils M; Hutchinson PJ; Katila AJ; Maanpää HR; Menon DK; Newcombe VF; Tallus J; Hrusovsky K; Wilson DH; Gill J; Sanchez JC; Tenovuo O; Zetterberg H; Blennow K
    J Neurotrauma; 2019 Jul; 36(14):2178-2189. PubMed ID: 30760178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
    Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
    J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early dynamics of glial fibrillary acidic protein and extracellular DNA in plasma of mice after closed head traumatic brain injury.
    Kmeťová K; Drobná D; Lipták R; Hodosy J; Celec P
    Neurochirurgie; 2022 Dec; 68(6):e68-e74. PubMed ID: 35810032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylenimine Modified Graphene-Oxide Electrochemical Immunosensor for the Detection of Glial Fibrillary Acidic Protein in Central Nervous System Injury.
    Khetani S; Ozhukil Kollath V; Kundra V; Nguyen MD; Debert C; Sen A; Karan K; Sanati-Nezhad A
    ACS Sens; 2018 Apr; 3(4):844-851. PubMed ID: 29516727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.